FibromiRs: Translating molecular discoveries into new anti-fibrotic drugs

Trends in Pharmacological Sciences

Volumn 35, Issue 3, 2014, Pages 119-126

  Pottier, Nicolas ^a   Cauffiez, Christelle ^a   Perrais, Michael ^b   Barbry, Pascal ^c,d   Mari, Bernard ^c,d  

^a UFR3S Pharmacie   (France)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

drug design; fibrosis; gene targeting; miRNA; therapeutics

Indexed keywords

ANTIFIBROTIC AGENT; FIBROMIR; MICRORNA; MICRORNA 1; MICRORNA 101; MICRORNA 15; MICRORNA 192; MICRORNA 199B; MICRORNA 200B; MICRORNA 208; MICRORNA 21; MICRORNA 24; MICRORNA 29B; MICRORNA 34A; MIRAVIRSEN; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

DRUG MECHANISM; FEEDBACK SYSTEM; FIBROGENESIS; FIBROSIS; GENE EXPRESSION; GENE SILENCING; HEART MUSCLE FIBROSIS; HEPATITIS C; HUMAN; KIDNEY FIBROSIS; LUNG FIBROSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY; TISSUE INJURY; WOUND HEALING;

DRUG DESIGN; FIBROSIS; GENE TARGETING; MIRNA; THERAPEUTICS;

ANIMALS; CICATRIX; FIBROSIS; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY;

EID: 84896727760     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.01.003     Document Type: Review

References (55)

1. S.L. Friedman et al. Therapy for fibrotic diseases: nearing the starting line Sci. Transl. Med. 5 2013 167sr1
2. T.A. Wynn Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases J. Clin. Invest. 117 2007 524 529
3. T.A. Wynn, and T.R. Ramalingam Mechanisms of fibrosis: therapeutic translation for fibrotic disease Nat. Med. 18 2012 1028 1040
4. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
5. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
6. R.C. Friedman et al. Most mammalian mRNAs are conserved targets of microRNAs Genome Res. 19 2009 92 105
7. E. van Rooij et al. Developing microRNA therapeutics Circ. Res. 110 2012 496 507
8. H.L. Janssen et al. Treatment of HCV infection by targeting microRNA N. Engl. J. Med. 368 2013 1685 1694
9. E. van Rooij et al. Control of stress-dependent cardiac growth and gene expression by a microRNA Science 316 2007 575 579
10. M. Kato et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN Nat. Cell Biol. 11 2009 881 889
11. S. Putta et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy J. Am. Soc. Nephrol. 23 2012 458 469
12. I. Karakikes et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling J. Am. Heart Assoc. 2 2013 e000078
13. C.A. Gebeshuber et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1 Nat. Med. 19 2013 481 487
14. H. Zhou et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1 J. Am. Soc. Nephrol. 24 2013 1073 1087
15. T. Bowen et al. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis J. Pathol. 229 2013 274 285
16. K.V. Pandit et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 182 2010 220 229
17. J. Milosevic et al. Profibrotic role of miR-154 in pulmonary fibrosis Am. J. Respir. Cell Mol. Biol. 47 2012 879 887
18. 2+ overload and cell death J. Clin. Invest. 122 2012 1222 1232
19. B.C. Bernardo et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function Proc. Natl. Acad. Sci. U.S.A. 109 2012 17615 17620
20. N. Liu et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart Genes Dev. 22 2008 3242 3254
21. P.A. da Costa Martins et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling Nat. Cell Biol. 12 2010 1220 1227
22. R.L. Montgomery et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure Circulation 124 2011 1537 1547
23. Z. Pan et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway Circulation 126 2012 840 850
24. T.G. Hullinger et al. Inhibition of miR-15 protects against cardiac ischemic injury Circ. Res. 110 2012 71 81
25. D. Macconi et al. MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition J. Am. Soc. Nephrol. 23 2012 1496 1505
26. A.M. Lakner et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis Hepatology 56 2012 300 310
27. D. Dakhlallah et al. Epigenetic regulation of miR-17∼92 contributes to the pathogenesis of pulmonary fibrosis Am. J. Respir. Crit. Care Med. 187 2013 397 405
28. N. Pottier et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial- mesenchymal interactions PLoS ONE 4 2009 e6718
29. C.L. Lino Cardenas et al. miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1 PLoS Genet. 9 2013 e1003291
30. T. Thum et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
31. E. van Rooij et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc. Natl. Acad. Sci. U.S.A. 105 2008 13027 13032
32. W.C. Tsai et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis J. Clin. Invest. 122 2012 2884 2897
33. S. Yang et al. miR-145 regulates myofibroblast differentiation and lung fibrosis FASEB J. 27 2013 2382 2391
34. B.N. Chau et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways Sci. Transl. Med. 4 2012 121ra18
35. J. Wang et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction J. Cell. Mol. Med. 16 2012 2150 2160
36. S. Oba et al. miR-200b precursor can ameliorate renal tubulointerstitial fibrosis PLoS ONE 5 2010 e13614
37. R.A. Boon et al. MicroRNA-34a regulates cardiac ageing and function Nature 495 2013 107 110
38. B. Maurer et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis Arthritis Rheum. 62 2010 1733 1743
39. W. Qin et al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29 J. Am. Soc. Nephrol. 22 2011 1462 1474
40. L. Cushing et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis Am. J. Respir. Cell Mol. Biol. 45 2011 287 294
41. C. Roderburg et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis Hepatology 53 2011 209 218
42. K.V. Pandit et al. MicroRNAs in idiopathic pulmonary fibrosis Transl. Res. 157 2011 191 199
43. G. Liu et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis J. Exp. Med. 207 2010 1589 1597
44. D. Bumcrot et al. RNAi therapeutics: a potential new class of pharmaceutical drugs Nat. Chem. Biol. 2 2006 711 719
45. C.F. Bennett, and E.E. Swayze RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform Annu. Rev. Pharmacol. Toxicol. 50 2010 259 293
46. V.J. Peschansky et al. RNAi joins the 'Singles Club' Mol. Ther. 20 2012 2010 2011
47. D. Yu et al. Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression Cell 150 2012 895 908
48. S. Michelfelder, and M. Trepel Adeno-associated viral vectors and their redirection to cell-type specific receptors Adv. Genet. 67 2009 29 60
49. J. Xiao et al. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice Mol. Ther. 20 2012 1251 1260
50. S. Obad et al. Silencing of microRNA families by seed-targeting tiny LNAs Nat. Genet. 43 2011 371 378
51. R.A. Boon et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation Circ. Res. 109 2011 1115 1119
52. J.P. Sheehan, and T.M. Phan Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism Biochemistry 40 2001 4980 4989
53. D.M. Patrick et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice J. Clin. Invest. 120 2010 3912 3916
54. B.N. Davis et al. SMAD proteins control DROSHA-mediated microRNA maturation Nature 454 2008 56 61
55. B.N. Davis et al. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha Mol. Cell 39 2010 373 384